A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function

Proc Natl Acad Sci U S A. 2001 May 8;98(10):5780-5. doi: 10.1073/pnas.091415198. Epub 2001 May 1.

Abstract

The role of the cardiac myocyte as a mediator of paracrine signaling in the heart has remained unclear. To address this issue, we generated mice with cardiac myocyte-specific deletion of the vascular endothelial growth factor gene, thereby producing a cardiomyocyte-specific knockout of a secreted factor. The hearts of these mice had fewer coronary microvessels, thinned ventricular walls, depressed basal contractile function, induction of hypoxia-responsive genes involved in energy metabolism, and an abnormal response to beta-adrenergic stimulation. These findings establish the critical importance of cardiac myocyte-derived vascular endothelial growth factor in cardiac morphogenesis and determination of heart function. Further, they establish an adult murine model of hypovascular nonnecrotic cardiac contractile dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Endothelial Growth Factors / genetics
  • Endothelial Growth Factors / metabolism*
  • Gene Expression Profiling
  • Heart / physiology*
  • Immunohistochemistry
  • In Situ Hybridization
  • Lymphokines / genetics
  • Lymphokines / metabolism*
  • Mice
  • Mice, Knockout
  • Models, Animal
  • Myocardium / metabolism*
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Endothelial Growth Factors
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors